3D Signatures Inc - TDSGF

3D Signatures Inc., a personalized medicine company, focuses on the development and commercialization of predictive technological products. Its proprietary software platform designed to predict the course of certain diseases and to personalize treatment for the individual patient. The company’s TeloView software platform measures the stage of the disease, rate of progression of the disease, how different diseases will respond to various therapies, drug efficacy, and drug toxicity. It is developing five diagnostic and prognostic products for cancers and neurological disorders, including Hodgkin’s lymphoma, prostate cancer, multiple myeloma, lung cancer, and Alzheimer’s diseases. The company is headquartered in Toronto, Canada.